Trials / Recruiting
RecruitingNCT07096999
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- University of Michigan Rogel Cancer Center · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being performed to establish the association between absorbed dose to tumor and response and absorbed dose to normal organs and toxicity following Lu177-PSMA radioligand therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-interventional study |
Timeline
- Start date
- 2025-01-23
- Primary completion
- 2031-01-23
- Completion
- 2031-01-23
- First posted
- 2025-07-31
- Last updated
- 2025-07-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07096999. Inclusion in this directory is not an endorsement.